News and Events

September 2016

Beacon Biomedical Inc. is named an AZBio Fast Lane Honoree for 2016, will be honored during the 11th Annual

AZBio Awards Dinner on September 21st at the Phoenix Convention Center, and will be presenting at the AZBio White Hat Investors Conference on September 22nd.

July 2016

Beacon Biomedical Inc. Appoints Industry Veteran to Lead Cancer Screening Technology Commercialization.

Beacon Biomedical Inc. moves to new corporate offices and announces the opening of its new R&D and CLIA laboratory facilities.

June 2016

Beacon Biomedical Inc. to Present at Singular Research Spring Select "Best of the Uncovereds" Investment Conference on June 9, 2016

May 2016

​Beacon Biomedical Inc. to Exhibit at BIO International Conference in San Francisco on June 6-9, 2016 

April 2016

Beacon Biomedical Inc. Appoints Industry Veteran To Lead Commercialization. Dave English had been appointed as Director of Business Development.

December 2015

Congratulations to Beacon Biomedical! They were named as 1 of the 6 winners in the Arizona Commerce Authority’s Fall 2015 round of the Arizona Innovation Challenge


Listen to Beacon Biomedical's CEO talk about their colon cancer screening test, ColoRT™ at ehealth radio

Beacon Biomedical, Inc., a privately held company focused on developing patient friendly cancer screening announced that it received an investment from Hyalescent Ventures.

October 2015

Beacon advances to the Semi-Finalist Round of the Arizona Commerce Authority's Fall 2015 Arizona Innovation Challenge as one of Top 25 Companies out of 131 applicants

September 2015

Beacon has been awarded a Phase I SBIR Grant for "Easy, Affordable & Accurate Point of Care Screening to Reduce Colorectal Cancer Disparities" from the National Institute of Biomedical Imaging and Biomedical Engineering at the National Institutes of Health.


Welcome To Beacon Biomedical

Beacon Biomedical Inc. is a medical diagnostic device company on a save as many lives as possible by providing easy, accurate and affordable blood tests for earlier cancer detection.
Our laboratory developed test (LDT) and point-of-care (POC) test solutions are being developed for primary care providers to be able to screen their patients for the presence of undiagnosed cancer.  Both of these test versions  can be completed with a few drops of blood, and our POC test is being specifically  designed to be used in-office providing doctors and their patients with real-time results in under 10-minutes.

Cancer Detection made easy, accurate and affordable...Welcome to the Beacon Revolution!


Easy, Accurate and Affordable Cancer Screening....Welcome to the Beacon Revolution!

  • 11:31
  • 10:38